SMS Pharmaceuticals Q2 Results

  • BSE: 532815
  • NSE: SMSPHARMA
  • ISIN: INE812G01025
  • Sector: Biotechnology & Drugs
BSE
248.257.00 (2.90%)
Volume25.28 K
Updated: Mon 25 Nov, 2024 | 15:29:45
NSE
246.14.95 (2.05%)
Volume1.13 L
Updated: Mon 25 Nov, 2024 | 15:31:30
Today: 242.05
248.35
52-Wk: 114.20
398.00

Q2 Results Highlights

  • Total Income
    ₹196.75 Cr.
    (19.64%)
  • Operating Profit
    ₹22.84 Cr.
    (-9.09%)
  • Profit After Tax
    ₹14.10 Cr.
    (-14.44%)
  • Operating Margin
    11.61%
    (-2.87%)
Note: Comparison is on YoY basis

Quarterly - SMS Pharmaceuticals Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 196.75135.34-%166.64-%
Selling/ General/ Admin Expenses Total 17.9313.55-%13.65-%
Depreciation/ Amortization 8.627.69-%7.90-%
Other Operating Expenses Total 9.677.72-%8.67-%
Total Operating Expense 173.90116.85-%146.72-%
Operating Income 22.8418.49-%19.92-%
Net Income Before Taxes 19.5412.68-%15.16-%
Net Income 14.109.34-%11.73-%
Diluted Normalized EPS 1.671.10-%1.39-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts